Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Rheumatology"
DOI: 10.1007/s10067-018-4005-6
Abstract: The objective of this study was to investigate risk factors for cytopenia when a prophylactic dose of trimethoprim-sulfamethoxazole (TMP-SMX) was co-administered with methotrexate (MTX). Patients who received MTX with or without a prophylactic dose of…
read more here.
Keywords:
dose;
dose tmp;
prophylactic dose;
tmp smx ... See more keywords